Silver price slumps hit SLV ETF and silver miner stocks as traders brace for US jobs data

Silver price slumps hit SLV ETF and silver miner stocks as traders brace for US jobs data

iShares Silver Trust (SLV) dropped 3.7% in after-hours trading Wednesday as spot silver fell 4.1% to $77.93 an ounce. Shares of First Majestic, Pan American, and Hecla Mining lost between 3.9% and 4.2%. J.P. Morgan estimates the upcoming Bloomberg Commodity Index rebalancing could trigger $3.8 billion in silver futures selling. Traders await Friday’s U.S. payrolls report for further direction.
Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14

Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14

Eli Lilly agreed to acquire Ventyx Biosciences for $14 per share in cash, valuing the company at about $1.2 billion. Ventyx shares closed up 37% at $13.81, while Lilly rose 4%. The deal is expected to close in the first half of 2026, pending shareholder approval. Investors await proxy filings and Lilly’s next earnings call for further details.
Dow Jones falls from intraday record as Trump policy moves hit financials; jobs report next

Dow Jones falls from intraday record as Trump policy moves hit financials; jobs report next

The Dow Jones fell 0.94% to 48,996.08 after Trump proposed banning Wall Street from buying single-family homes and restricting defense contractor payouts, sending financial and defense stocks lower. JPMorgan dropped 2.3% after a downgrade. Nvidia and Alphabet gains lifted the Nasdaq 0.16%. Investors await Friday’s U.S. payrolls report for rate signals.
Goldman Sachs stock falls after Apple Card handoff report — here’s what investors watch next

Goldman Sachs stock falls after Apple Card handoff report — here’s what investors watch next

Goldman Sachs shares dropped 1.7% after hours to $941.02 following a Wall Street Journal report that JPMorgan Chase will take over the $20 billion Apple Card portfolio. Goldman is expected to sell the balances at a discount exceeding $1 billion. Investors are watching for details on consumer-exit costs when Goldman reports fourth-quarter results on Jan. 15.
AST SpaceMobile (ASTS) stock sinks 12% after Scotiabank downgrade calls valuation ‘irrational’

AST SpaceMobile (ASTS) stock sinks 12% after Scotiabank downgrade calls valuation ‘irrational’

AST SpaceMobile shares dropped 12.1% to $85.73 after Scotiabank downgraded the stock to sector underperform and set a $45.60 target, citing high valuation and the need to build out its satellite network. The stock had surged 324% over the past year. AST aims to launch 45–60 satellites by end-2026 but has no retail customers yet. Investors await updates on launch schedules and the next earnings report.
7 January 2026
UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth Group shares fell 2% to $341.70 in after-hours trading Wednesday, following a late-session slide. The drop came as investors weighed a possible Optum UK sale to TPG for up to $1.89 billion and awaited the company’s Jan. 27 earnings report. Peers Cigna, CVS Health, and Elevance Health also declined. U.S. job openings hit a 14-month low, further pressuring market sentiment.
Boeing stock slips after-hours despite Alaska Airlines’ record jet order, with earnings next on Jan. 27

Boeing stock slips after-hours despite Alaska Airlines’ record jet order, with earnings next on Jan. 27

Boeing shares fell 0.7% in after-hours trading to $228.12 after Alaska Airlines announced an order for 110 jets, mostly 737-10s. The 737-10 still awaits FAA certification, raising questions about delivery timelines. Alaska’s order includes 105 737-10s and five 787s, with options for 35 more jets. Investors are watching for regulatory updates and Boeing’s Jan. 27 earnings report.
7 January 2026
Lockheed Martin stock slides after Patriot missile deal, Goldman sticks to $430 sell target

Lockheed Martin stock slides after Patriot missile deal, Goldman sticks to $430 sell target

Lockheed Martin signed a seven-year deal with the U.S. Department of War to boost annual PAC-3 missile production from about 600 to 2,000 units. The company delivered a record 620 missiles in 2025 and expects the new program to add thousands of jobs. Lockheed shares fell 4.8% Wednesday, while President Trump threatened to block defense contractor dividends and buybacks unless production speeds up.
Netflix stock steadies after Warner board rejects Paramount bid again, earnings next

Netflix stock steadies after Warner board rejects Paramount bid again, earnings next

Netflix shares rose 0.1% to $90.73 after hours Wednesday as Warner Bros. Discovery urged shareholders to reject Paramount Skydance’s revised offer and stick with Netflix’s merger deal. Warner’s board called Paramount’s bid risky and debt-heavy. Paramount Skydance shares fell 1.1%. Warner shareholders have until Jan. 21 to tender shares into Paramount’s offer.
Sandisk Corporation stock steadies after CES-fueled spike as Jan. 29 earnings loom

Sandisk Corporation stock steadies after CES-fueled spike as Jan. 29 earnings loom

Sandisk shares climbed 1.2% to $353.56 in after-hours trading Wednesday, outperforming Western Digital and Seagate, which fell sharply. The stock extended gains after Nvidia CEO Jensen Huang’s CES remarks on new storage technology. Investors await Sandisk’s Jan. 29 results for updates on NAND pricing and AI demand. Sandisk completed its split from Western Digital in February 2025.
Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus

Eli Lilly stock jumps after $1.2B Ventyx buy as obesity-pill bets come into focus

Eli Lilly shares rose 4.1% to $1,108.09 after the company agreed to acquire Ventyx Biosciences for $1.2 billion in cash. Ventyx holders will receive $14 per share, a 62% premium to its 30-day VWAP. The deal is expected to close in the first half of 2026, pending regulatory and shareholder approval. Lilly also announced a multi-year obesity drug partnership with Nimbus Therapeutics.

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop